Mano Iyer
Private Equity Investor at Sofinnova Partners SAS
Profile
Manohar (Mano) Iyer - Venture Partner
Manohar (Mano) Iyer, a serial entrepreneur whose ties with Sofinnova Partners stretch back more than 15 years, rejoined the firm in October, 2022.
As a Venture Partner, Mano investigates global medical device investment opportunities across the Sofinnova Partners platform of strategies, with a particular focus on helping the firm’s in-house medtech accelerator, Sofinnova MD Start, incubate world-class companies.
In 2008, Mano was among the co-founders of the original MD Start team that incubated companies including CorWave and LimFlow.
He also advised CoreValve, a Sofinnova Capital Strategy portfolio company, which was subsequently purchased by Medtronic for $800 million.
Mano founded ReCor Medical during his time as an Entrepreneur-in-Residence at Sofinnova Partners in 2009.
He left Sofinnova in 2013 to work full-time as the Chief Operating Officer of ReCor, which was successfully sold to Otsuka Medical Devices in 2018.
Mano started his career in medical devices as an engineer at Arrow International.
Mano holds an MBA from Stanford and a Bachelor of Science in Mechanical Engineering from the Rochester Institute of Technology.
Mano Iyer active positions
| Companies | Position | Start |
|---|---|---|
Sofinnova Partners SAS
 Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Private Equity Investor | 2022-09-30 |
Former positions of Mano Iyer
| Companies | Position | End |
|---|---|---|
ReCor Medical, Inc.
 ReCor Medical, Inc. Pharmaceuticals: MajorHealth Technology ReCor Medical, Inc. develops novel therapeutic ultrasound catheter technologies The firm develops a therapeutic non-focused ultrasound system for performing renal denervation in patients with resistant hypertension. The company was founded by Mano Iyer and Jacques Seguin in July 2009 and is headquartered in Palo Alto, CA. | Founder | 2022-07-30 |
HighLife SAS
 HighLife SAS Medical SpecialtiesHealth Technology HighLife SAS develops percutaneous mitral valve replacement therapies. It offers a minimally invasive prosthetic mitral valve that is implanted on a beating heart, while preserving the native valve structure and respecting the surrounding anatomy. The company was founded by Georg Börtle in 2010 and is headquartered in Paris, France. | Director/Board Member | 2018-12-30 |
MD Start SA
 MD Start SA BiotechnologyHealth Technology MD Start SA develops medical device technology. It has collaboration between venture capital, institutional investors and industry to the development of innovative medtech ideas in Europe. The company was founded by Tim Lenihanin 2010 and is headquartered in Paris, France. | Chief Investment Officer | - |
Training of Mano Iyer
| Rochester Institute of Technology | Undergraduate Degree |
| Stanford University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
MD Start SA
MD Start SA BiotechnologyHealth Technology MD Start SA develops medical device technology. It has collaboration between venture capital, institutional investors and industry to the development of innovative medtech ideas in Europe. The company was founded by Tim Lenihanin 2010 and is headquartered in Paris, France. | Health Technology |
ReCor Medical, Inc.
ReCor Medical, Inc. Pharmaceuticals: MajorHealth Technology ReCor Medical, Inc. develops novel therapeutic ultrasound catheter technologies The firm develops a therapeutic non-focused ultrasound system for performing renal denervation in patients with resistant hypertension. The company was founded by Mano Iyer and Jacques Seguin in July 2009 and is headquartered in Palo Alto, CA. | Health Technology |
HighLife SAS
HighLife SAS Medical SpecialtiesHealth Technology HighLife SAS develops percutaneous mitral valve replacement therapies. It offers a minimally invasive prosthetic mitral valve that is implanted on a beating heart, while preserving the native valve structure and respecting the surrounding anatomy. The company was founded by Georg Börtle in 2010 and is headquartered in Paris, France. | Health Technology |
Sofinnova Partners SAS
Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Finance |
- Stock Market
- Insiders
- Mano Iyer
